Going to be huge when it goes off patent off exclusivity. I'd also expect you'll be able to get it when it's made in jurisdictions that will ignore the patent. Up to you to get it from those places, either via mail or travel runs.
https://www.usnews.com/news/best-states/articles/2018-11-01/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523158/
https://www.cnn.com/2023/03/07/health/fda-drug-shipments-khn...
https://www.usatoday.com/story/news/health/2022/12/14/states...
Also, I expect CRISPR or gene therapy to be the long game wrt this and updating the body's GLP-1 regulation, versus maintenance doses of a pharma product. This is a shim.
https://benmay.uchicago.edu/crispr-gene-therapy
https://www.creative-biogene.com/crispr-cas9/solution/glp1r-...